FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• HIPK2 (Homeodomain-Interacting Protein Kinase 2) is involved in regulating transcriptional activation.
• p53 is a critical tumor suppressor protein that controls cell cycle and apoptosis.
• Understanding the regulatory mechanisms of p53 is vital for cancer research.

Purpose of the Study:

• To identify proteins interacting with HIPK2 to elucidate its regulatory role.
• To investigate the functional consequence of HIPK2-interacting proteins on p53 transcriptional activity.

Main Methods:

• Yeast two-hybrid screening to identify HIPK2 interacting proteins.
• In vitro (GST pull-down) and in vivo (immunoprecipitation, fluorescence microscopy) assays to confirm protein interactions.
• Reporter gene assays and chromatin immunoprecipitation (ChIP) to assess transcriptional regulation and promoter recruitment.

Main Results:

• Four and a half LIM domains 2 (FHL2) was identified as a HIPK2-interacting protein.
• FHL2 and HIPK2 co-expression led to FHL2 redistribution within the nucleus.
• HIPK2 enhanced FHL2's transcriptional activity, and FHL2 amplified p53-dependent transcription, requiring HIPK2's kinase activity.
• A ternary complex of p53, HIPK2, and FHL2 was detected and shown to be recruited to the p21Waf1 promoter.

Conclusions:

• FHL2 directly interacts with HIPK2.
• FHL2 modulates p53 transcriptional activity through its association with HIPK2.
• This interaction represents a novel regulatory pathway for p53 function.